Four Nova Scotia clean technology start-ups are getting a boost towards investment readiness through Innovacorp’s CleanTech Development Program.
Appili Therapeutics Inc. (Appili), a biopharmaceutical company focused on anti-infective drug development and commercialization, today announced that Halifax Chamber of Commerce presented Appili with the 2018 New Business of the Year award.
Two Nova Scotia ocean technology companies are each receiving $50,000 in funding through Innovacorp’s Blue Solutions Start-Up Challenge. The companies will use the money to further develop their technologies.
Early stage technology companies will soon have more access to venture capital.
SkySquirrel Technologies Inc. and VineView Imaging, leading providers of aerial imaging and crop diagnostics for vineyards, have announced a merger of the two companies. The merger is effective today, and the companies plan to begin integrating operations, customers, global partners and employees immediately.
Appili Therapeutics Inc. (Appili), an anti-infective drug development company, announced today it has signed a licence agreement with the National Research Council of Canada (NRC) to develop ATI-1701, a vaccine to protect against Francisella tularensis, a potential bioterrorism agent that causes tularemia.
Thomas Concrete to install CarbonCure's technology at 16 additional plants across Georgia and the Carolinas, making it the world's largest supplier of concrete made with award-winning CO2 recycling technology.
More venture capital will be available to technology start-up companies in Nova Scotia and the rest of Atlantic Canada with the creation of two private-sector venture capital funds.
DM-Density personalized breast density reporting software will be offered via vendor neutral artificial intelligence distribution platform